NLS Pharmaceutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLSP and other ETFs, options, and stocks.

About NLSP

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. 

CEO
Alexander Zwyer
CEOAlexander Zwyer
Employees
2
Employees2
Headquarters
Zurich, Zurich
HeadquartersZurich, Zurich
Founded
2015
Founded2015
Employees
2
Employees2

NLSP Key Statistics

Market cap
5.53M
Market cap5.53M
Price-Earnings ratio
-0.28
Price-Earnings ratio-0.28
Dividend yield
—
Dividend yield—
Average volume
139.24K
Average volume139.24K
High today
$0.1399
High today$0.1399
Low today
$0.131
Low today$0.131
Open price
$0.1313
Open price$0.1313
Volume
123.84K
Volume123.84K
52 Week high
$1.53
52 Week high$1.53
52 Week low
$0.113
52 Week low$0.113
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.